Skip to main content
. 2008 Nov 10;26(35):5689–5696. doi: 10.1200/JCO.2008.16.4731

Table A1.

Selected Baseline or Breast Cancer Characteristics of Respondents and Nonrespondents to the 2004 IWHS Follow-Up Survey With Unilateral Breast Cancer Between 1986 and 2003

Characteristic % of Patients
All Respondents (n = 1,287) Nonrespondents
All (n = 1,370) Alive in 2004 (n = 651) Died Before 2004 (n = 719)
Age at baseline, years
    Mean 61.0 62.6 62.3 63.0
    SE 0.1 0.1 0.2 0.2
Age at diagnosis, years
    Mean 71.0 71.0 72.2 70.0
    SE 0.2 0.2 0.2 0.2
Time since breast cancer diagnosis, years
    Mean 8.1 8.2
    SE 0.1 0.2
Baseline BMI ≥ 25 kg/m2 63.9 66.8 65.6 67.9
Comorbidity index, yes* 57.2 56.5 52.2 60.4
Tumor size, mm*
    < 10 mm 29.7 21.7 28.3 16.7
    10-19 mm 36.4 31.0 34.9 27.4
    ≥ 20 mm 23.8 35.5 26.4 43.7
    Unknown 10.1 11.7 10.5 12.2
Breast cancer stage*
    In situ 13.1 9.6 12.8 7.1
    Local 58.2 52.4 58.0 48.5
    Regional/distant 13.9 28.6 16.1 38.7
    Unstaged 14.6 9.3 13.1 5.7
Type of surgery*
    No surgery 17.6 14.6 1.1 4.6
    Lumpectomy 17.1 15.2 35.0 20.3
    Simple 14.5 12.7 4.2 3.3
    Radical 48.7 53.5 46.5 67.3
    Other 4.0 4.0 0.8 4.5
Breast cancer histologic type
    Ductal 78.1 73.3 76.2 71.5
    Lobular 7.6 8.4 7.2 9.2
    Mixed 6.0 4.7 5.2 4.0
    Other 8.4 13.6 11.4 15.3
ER status
    Positive 65.6 62.9 65.3 60.4
    Negative 11.5 13.0 10.6 15.4
    Unknown 23.0 24.1 24.1 24.2
PR status
    Positive 54.4 52.6 54.8 50.2
    Negative 19.3 21.1 18.6 23.4
    Unknown 26.3 26.3 26.6 26.4
No. of nodes examined
    Mean 11.1 10.8 10.2 11.4
    SE 0.2 0.3 0.3 0.4
Positive lymph nodes present, SEER 14.4 25.8 14.8 29.5

NOTE. Respondents include Iowa Women's Health Study (IWHS) women with unilateral breast cancer (according to Surveillance, Epidemiology, and End Results [SEER]) who responded to the 2004 follow-up and answered questions about lymphedema and arm symptoms on follow-up. Nonrespondents include all other IWHS women with unilateral breast cancer.

Abbreviations: BMI, body mass index; ER, estrogen receptor; PR, progesterone receptor.

*

Derived from baseline and follow-up questionnaires; includes participants with a history of hypertension, heart disease, and/or diabetes.

Data from SEER.

Information on nodes only available since 1988; women diagnosed with unilateral breast cancer during or after 1988 are included (total, n = 1,210; alive, n = 614; dead, n = 596).